Glenmark Pharmaceuticals Ltd. - Research Center

---

(Rs crore)

Profit loss account

	Mar ' 09	Mar ' 08	Mar ' 07	Mar ' 06	Mar ' 05
Income
Operating income	865.09	1,379.82	809.79	565.34	495.45
Expenses
Material consumed	225.73	437.27	258.77	201.78	157.82
Manufacturing expenses	23.59	37.54	32.03	26.91	24.02
Personnel expenses	110.90	108.91	78.21	60.11	49.49
Selling expenses	120.94	134.16	91.62	72.14	65.66
Adminstrative expenses	152.28	159.08	133.77	98.54	83.59
Expenses capitalised	-	-	-	-	-
Cost of sales	633.44	876.95	594.40	459.48	380.58
Operating profit	231.65	502.87	215.40	105.86	114.87
Other recurring income	41.47	8.05	19.92	13.64	3.74
Adjusted PBDIT	273.13	510.92	235.32	119.50	118.61
Financial expenses	94.81	43.64	39.36	17.45	16.73
Depreciation	19.10	29.44	23.46	17.48	14.98
Other write offs	-	-	-	-	-
Adjusted PBT	159.21	437.84	172.50	84.56	86.90
Tax charges	27.22	42.16	33.97	18.00	23.45
Adjusted PAT	132.00	395.67	138.53	66.57	63.44
Non recurring items	86.86	-6.65	-1.68	0.74	0.04
Other non cash adjustments	-0.93	-	-2.04	-	-
Reported net profit	217.93	389.02	134.80	67.30	63.48
Earnigs before appropriation	781.61	623.76	280.44	163.71	113.17
Equity dividend	10.02	17.15	9.58	8.31	8.30
Preference dividend	-	-	0.69	1.40	0.71
Dividend tax	1.70	2.92	1.44	1.36	1.26
Retained earnings	769.89	603.69	268.73	152.64	102.91

© Copyright 2009 Rediff.com India Limited. All rights reserved. DisclaimerTerms of ServicePrivacy PolicyFeedback